Search research articles
Contact Us
Filters
Showing results (41-50 of 103) with videos related to
Page
of 11
Sort By:
Antimicrobial Agents and Chemotherapy
|
November 29, 2017
Azithromycin Pharmacodynamics against Persistent Haemophilus influenzae in Chronic Obstructive Pulmonary Disease
Brian T Tsuji, James Fisher, Raheal Boadi-Yeboah, et al.
Antimicrobial Agents and Chemotherapy
|
September 21, 2011
Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections
Jill M Butterfield, Brian T Tsuji, Jack Brown, et al.
The Journal of Antimicrobial Chemotherapy
|
November 18, 2017
Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models
Cornelia B Landersdorfer, Jiping Wang, Veronika Wirth, et al.
The Journal of Antimicrobial Chemotherapy
|
August 14, 2016
Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa
Vanessa E Rees, Jürgen B Bulitta, Antonio Oliver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 7, 2011
Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dosing regimen: raising Lazarus from the dead
Brian T Tsuji, Olanrewaju O Okusanya, Jurgen B Bulitta, et al.
Diagnostic Microbiology and Infectious Disease
|
April 26, 2011
Evaluation of the pharmacokinetics-pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selection
Olanrewaju O Okusanya, Brian T Tsuji, Jurgen B Bülitta, et al.
Pharmacotherapy
|
December 1, 2010
Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing
Lauren M Lim, Neang Ly, Dana Anderson, et al.
Antimicrobial Agents and Chemotherapy
|
August 31, 2011
Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula
Phillip J Bergen, Alan Forrest, Jürgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy
|
April 29, 2015
Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutators
Zackery P Bulman, Mark D Sutton, Neang S Ly, et al.
The Journal of Antimicrobial Chemotherapy
|
June 12, 2012
Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations
Brian T Tsuji, Jurgen B Bulitta, Tanya Brown, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 103) with videos related to
Sort By:
Page
of 11
Antimicrobial Agents and Chemotherapy
|
November 29, 2017
Azithromycin Pharmacodynamics against Persistent Haemophilus influenzae in Chronic Obstructive Pulmonary Disease
Brian T Tsuji, James Fisher, Raheal Boadi-Yeboah, et al.
Antimicrobial Agents and Chemotherapy
|
September 21, 2011
Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections
Jill M Butterfield, Brian T Tsuji, Jack Brown, et al.
The Journal of Antimicrobial Chemotherapy
|
November 18, 2017
Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models
Cornelia B Landersdorfer, Jiping Wang, Veronika Wirth, et al.
The Journal of Antimicrobial Chemotherapy
|
August 14, 2016
Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa
Vanessa E Rees, Jürgen B Bulitta, Antonio Oliver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 7, 2011
Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dosing regimen: raising Lazarus from the dead
Brian T Tsuji, Olanrewaju O Okusanya, Jurgen B Bulitta, et al.
Diagnostic Microbiology and Infectious Disease
|
April 26, 2011
Evaluation of the pharmacokinetics-pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selection
Olanrewaju O Okusanya, Brian T Tsuji, Jurgen B Bülitta, et al.
Pharmacotherapy
|
December 1, 2010
Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing
Lauren M Lim, Neang Ly, Dana Anderson, et al.
Antimicrobial Agents and Chemotherapy
|
August 31, 2011
Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula
Phillip J Bergen, Alan Forrest, Jürgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy
|
April 29, 2015
Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutators
Zackery P Bulman, Mark D Sutton, Neang S Ly, et al.
The Journal of Antimicrobial Chemotherapy
|
June 12, 2012
Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations
Brian T Tsuji, Jurgen B Bulitta, Tanya Brown, et al.
Page
of 11